David Kerr

DM FRCP FRCPE
David Kerr, DM FRCP FRCPE

David Kerr

MBChB DM FRCPE FRCP

Santa Barbara, CA

“We are our choices”

Current

  • Senior Investigator
    Diabetes Research and Digital Health Equity,
    Sutter Center for Health Systems Research
  • Adjunct Professor, Dept Electrical and Computer Engineering, Rice University
  • Scientific Advisory Board, PATHS-UP (https://pathsup.org)
  • Research Committee, Association of Diabetes Care and Education Specialists (https://www.diabeteseducator.org)

Previously

  • Director of Research and Innovation, Sansum Diabetes Research Institute
  • Consultant Physician, Bournemouth Diabetes and Endocrine Center, UK

Interests

  • Digital Health
  • Food-as-Medicine
  • Health Equity

Recent Publications & Media

Research

  • Simonson GD, Criego A, Battelino T, Carlson AL, Choudhary P, Franc S, Gershenoff D, Grunberger G, Hirsch IB, Isaacs D, Johnson M, Kerr D, et al. Expert Panel Recommendations for a Standardized Ambulatory Glucose Profile Report for Connected Insulin Pens. Diabetes Technol Ther. 2024 May 17. doi: 10.1089/dia.2024.0107. Epub ahead of print.
  • Klonoff DC, Kim SH, Galindo RJ, Joseph JI, Garrett V, Gombar S, Aaron RE, Tian T, Kerr D. Risks of peri- and postoperative complications with glucagon-like peptide-1 receptor agonists. Diabetes Obes Metab. 2024 May 14. doi: 10.1111/dom.15636. Epub ahead of print.
  • Tian T, Aaron RE, DuNova AY, Jendle JH, Kerr D, et al. Diabetes Technology Meeting 2023. J Diabetes Sci Technol. 2024 Mar 25:19322968241235205. doi: 10.1177/19322968241235205. Epub ahead of print.
  • Klonoff DC, Aaron RE, Tian T, DuNova AY, Pandey A, Rhee C, Fleming GA, Sacks DB, Pop-Busui R, Kerr D. Advanced Glycation Endproducts: A Marker of Long-term Exposure to Glycemia. J Diabetes Sci Technol. 2024 Mar 25:19322968241240436. doi: 10.1177/19322968241240436. Epub ahead of print.
  • Kerr D, Rajpura JR, Namvar T. Evaluating Patient and Provider Preferences for a Once-Weekly Basal Insulin in Adults with Type 2 Diabetes. Patient Prefer Adherence. 2024 Feb 14;18:411-424.
  • Pai A, Santiago R, Glantz N, Bevier W, Barua S, Sabharwal A and Kerr D. Multimodal digital phenotyping for meal characterization in Hispanic/Latino adults with or at risk of type 2 diabetes. NPJ Digital Medicine 2024; 7: 7: https://doi.org/10.1038/s41746-023-00985-7
  • Kalyani R, Allende-Vigo M, Antinori-Lent, Close K, Das S, Deroze P, Edelman S, El Sayed N, Kerr D, Neumiller J and Norton A. Prioritizing patient experiences in the management of diabetes and its complications: An Endocrine Society Position Statement. Journal of Clinical Endocrinology and Metabolism 2024; Feb 21st: 1-24. https://doi.org/10.1210/clinem/dgad745
  • Barua S, Sabharwal A, Glantz N, Conneely C, Larez A, Bevier W and Kerr D. A probabilistic reimagination of the dawn phenomenon. Insights from continuous glucose monitoring in an underserved population. Nature Scientific Reports 2024 Feb 5; 14(1): 2915. https://www.nature.com/articles/s41598-024-52461-1
  • Ebekozien O, Fantasia K, Farnoosh F, Sabharwal A and Kerr D. Technology and health inequities in diabetes care: How do we widen access to underserved populations & utilize technology to improve outcomes for all? Diabetes Obesity & Metabolism 2024; Jan 31: https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15470
  • Kerr D, Duncan I, Repetto E, Maroun R, Wu A, Perkins C, Bergman G and Giorgino F. Cost Analysis of Self-Monitoring Blood Glucose in Non Intensively Managed Type 2 Diabetes . American Journal of Managed Care 2023: 29: 12.
  • Tian T, Aaron RE, Huang J, Yeung AM, Svensson J, Gentile S, Forbes A, Heinemann L, Seley J, Kerr D, Klonoff D. Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society. J Diabetes Sci Technol. 2023 Aug 9th:19322968231187661.
  • Sato E, Sabharwal A, Conneely C, Glantz N, Bevier W, Barua S, Pai A, Larez A and Kerr D. Farming for Life: Temporal changes in glycemia following a medical produce prescription program for predominantly Mexican American adults. Helyion Cell Press 2023; July 20th
  • J, Yeung AM, Klonoff DC, Abdel-Malek A, Ahn DT, Kerr D. People with Diabetes Using Insulin Flying Across Multiple Time Zones – Limitations and Opportunities for Diabetes Technologies. Endocrine Practice. 2023 Jul 15:S1530-891X(23)00472-X. doi: 10.1016/j.eprac.2023.07.003. Epub ahead of print.
  • Klonoff DC, Yeung AM, Huang J, Espinoza JC, Raymond JK, Lee WA, Koliwad SK, Kerr D. Twenty-first century management of diabetes with shared telemedicine appointments. Journal of Telemedicine and Telecare. 2023 Jul 20:1357633X231184503. doi: 10.1177/1357633X231184503. Epub ahead of print.
  • Duncan I, Kerr D, Aggarwal R, Huynh N. New Drugs for Obesity, Is the Excitement Affordable? Popul Health Manag. 2023 Jun 5. doi: 10.1089/pop.2023.0086. Epub ahead of print.
  • Yeung AM, Huang J, Pandey A, Hashim IA, Kerr D, et al. Biomarkers for the diagnosis of heart failure in people with diabetes: A consensus report from diabetes technology society. Progress in Cardiovascular Disease. 2023 May 11th: Epub ahead of print.
  • Huang J, Yeung AM, Kerr D, et al. Lipohypertrophy and Insulin. An Old Dog that Needs New Tricks. Endocrine Practice. 2023 Apr 23. Epub ahead of print.
  • Klonoff DC, Kerr D, Clark L. Barriers and Solutions to Trends and Disparities in Glycemic Control and Severe Hyperglycemia Among US Adults With Diabetes Using Insulin From 1988 to 2020. J Diabetes Sci Technol. 2023 Feb 17th.
  • Huang J, Yeung AM, Kerr D, Klonoff DC. Using ChatGPT to Predict the Future of Diabetes Technology. J Diabetes Sci Technol. 2023 Feb 17th.
  • Kerr D, Klonoff DC, Bergenstal RM, Choudhary P, Ji L. A Roadmap to an Equitable Digital Diabetes Ecosystem. Endocrine Practice. 2022 Dec 28: S1530-891X(22)00908-9.
  • Kerr D, et al. New Digital Health Technologies for Insulin Initiation and Optimization for People With Type 2 Diabetes. Endocr Pract. 2022 Aug;28(8):811-821
  • Kerr D, Klonoff D. Breakthrough technology for in-hospital glucose monitoring. Lancet Diabetes Endocrinol. 2022 May;10(5):304-306.
  • Kerr D, et al. Patterns of Timing and Intensity of Physical Activity and HbA1c Levels in Hispanic/Latino Adults With or at Risk of Type 2 Diabetes. J Diabetes Sci Technol. 2022 Jun 30:19322968221105531.
  • Kerr D, et al. A persisting parallel universe in diabetes care within America’s capital. Lancet EClinicalMedicine. 2021 Dec 24;43:101244

Get the latest news

Name